The genes for Clostridium difficile toxins A and B (tcdA and tcdB) are part of a 19.6-kb pathogenicity locus (PaLoc) that includes the genes tcdD, tcdE, and tcdC. To determine whether the C. difficile PaLoc is a stable and conserved genetic unit in toxigenic strains, a multiplex polymerase chain reaction was used to analyze 50 toxigenic, 39 nontoxigenic, and 2 toxin-defective isolates. The respective amplicons were identified for tcdA-E in the toxigenic isolates; these were absent in the nontoxigenic isolates. C. difficile P-829 lacked at least a fragment of tcdD, tcdB, tcdE, and tcdC, but tcdA was present. C. difficile 8864 had deletions in the tcdA and tcdC genes. These data suggest that the PaLoc is highly stable in toxigenic C. difficile, nontoxigenic isolates lack the unit, and isolates with a defective PaLoc can still cause clinical disease. Further studies are needed to define the role of individual genes in the pathogenesis of C. difficile-associated diarrhea.
The pathogenicity of Clostridium difficile is associated with its ability to produce 2 toxins: toxin A, an enterotoxin, and toxin B, a potent cytotoxin [1] . The genes for toxins A and B (tcdA and tcdB) are part of a 19.6-kb genetic locus that includes 3 additional small open-reading frames (ORFs), tcdD, tcdE, and tcdC, and is considered a prerequisite for virulence. In nontoxigenic strains, the pathogenicity locus (PaLoc) is not present, and a 115-bp DNA fragment is found between the 2 insertion sequences [2, 3] . The ORFs for the insertion sequences, cdu 2/2 and cdd 2-3, located upstream and downstream, respectively, from the PaLoc, are present in nontoxigenic strains [3] . The function of these genes or their role in the virulence of C. difficile is not known; however, cdu-2 has some similarity to bacterial repressors and to Na ϩ /H ϩ antiporters [3] . Until recently it was thought that the only genes associated with virulence were tcdA and tcdB and that all toxigenic strains produced both toxins A and B, whereas nontoxigenic strains lacked both genes and were avirulent. Hammond and Johnson [2] and Braun et al. [3] defined the PaLoc of C. difficile VPI 10463 and found that this gene cluster was conserved in 5 toxigenic strains but absent in 5 nontoxigenic strains analyzed. Transcriptional analysis of tcdA-E showed that the 5 genes are transcribed in a coordinate fashion according to phase of growth [4, 5] . Transcription of tcdC is high in early exponential growth phase, whereas transcription of tcdA-E is high in late stationary phase. These studies suggest that tcdC is a negative regulator of toxin production, whereas tcdD has a positive regulatory function [4] . Aside from these studies, little is known about the stability and the role or function of tcdC-E in the virulence of C. difficile. The goal of this study was to determine whether the PaLoc is a conserved and stable genetic unit in toxigenic C. difficile and to investigate this genetic unit in toxindeficient mutant strains.
Materials and Methods
C. difficile strains. The strains of C. difficile analyzed in this study and their sources are listed in tables 1 and 2. We consider strains to be toxigenic if they carry the toxin A and B genes, as determined by polymerase chain reaction (PCR). Nontoxigenic strains lack the toxin A and B gene fragments targeted by our primers. Since no cytotoxicity assay was performed on the stool of patients from Belarus, toxin A production was assessed in clinical isolates Bel P-1 through Bel P-6. All strains were grown anaerobically on the selective medium cycloserine-cefoxitin-fructose agar [10] at 37ЊC for 48 h. Strains were maintained in cooked meat broth.
DNA extraction. DNA was extracted as described elsewhere [11] . In brief, an isolated colony from each strain was transferred with an inoculating loop into a 0.6-mL microcentrifuge tube containing 100 mL of sterile water and was boiled at 100ЊC for 10 min. After boiling, the sample was centrifuged at low speed (3000 g) to remove cell debris. The supernatant containing the DNA was used for amplification reactions.
Amplification of toxin A and B genes. Toxin A and B genes were amplified as described elsewhere [12, 13] . The sequences of the primers used and respective size of the amplicons are shown in table 3 .
Amplification of genes tcdC-E, cdu-2, and cdd-3 by a multiplex PCR approach. Amplification of the genes tcdC-E, cdu-2, and cdd-3 was done as described by Braun et al. [3] . In brief, a multiplex PCR was performed with the thermostable DNA polymerase (rTaq; Perkin Elmer-Cetus, Norwalk, CT) in a final volume of 100 a For C. difficile Bel P-1 through P-6 and C-1 through C-3, toxin A production was confirmed by TOX A ELISA, since cytotoxin analysis was not performed on patient stool samples. b For isolates P-829 and 8864, toxin A and B production was not assessed. Table 2 . Nontoxigenic Clostridium difficile strains analyzed (from this study).
Isolate Source Cytotoxin P-776, P-783, P-838, P-839, P-881, P-888, P-917, P-922, P-938, P-939, P-940, P-941, P-942, P-944, P-952 The reaction mixtures were covered with 100 mL of mineral oil to prevent evaporation. In all cases, a negative control containing all PCR reagents (without DNA) was used to monitor contamination. The PCR profile included a denaturing step at 95ЊC for 1 min and annealing at 52ЊC for 1 min followed by extension at 72ЊC for 1 min for 40 cycles. A final extension step was done for 10 min at 72ЊC.
Detection of amplified products. Amplified products were visualized by running 9 mL of the reaction mixture in 2% agarose (Gibco BRL, Grand Island, NY) gels in Tris-borate EDTA (TBE). Gels were run in TBE at a constant 110 V for 90 min. Size markers included in all gels were the 123-bp DNA ladder (Gibco BRL). Gels were stained in an ethidium bromide solution (0.5 mg/mL) for 30 min, destained for 30 min, and photographed under UV light with a Land camera (Polaroid Corporation, Cambridge, MA).
Determination of toxin A and B production in C. difficile P-829 and 8864. Toxin A production was assessed by the C. difficile TOX A-Test ELISA kit (Techlab, Blacksburg, VA) as instructed by the manufacturer. Production of toxin B was detected by the cytotoxicity assay, as described elsewhere [14] .
Results
No enterotoxin or cytotoxin activity was detected in C. difficile P-829 as determined by the TOX A-ELISA for toxin A and the cytotoxicity assay for toxin B. C. difficile 8864 did not produce toxin A; however, it was highly cytotoxic by the tissue culture assay. Since no clinical test was performed on the stool of patients from Belarus, isolates Bel P-1 through Bel P-6 were shown to produce toxin A by the TOX A-ELISA kit. All other isolates are described in tables 1 and 2.
By using primer pairs directed at the toxin A and B genes and at genes tcdD, tcdE, and tcdC of the PaLoc of C. difficile, we amplified the expected amplicons in all 50 toxigenic isolates analyzed. No amplification products were obtained with DNA from 39 nontoxigenic strains. Only the sequences at the integration sites (cdu-2/cdd-3) were amplified from the nontoxigenic isolates, as expected ( figures 1 and 2 ). Since all toxigenic strains analyzed carried the PaLoc genes, and the nontoxigenic strains lacked these genes, table 4 and figures 1 and 2 show only representative C. difficile strains. C. difficile P-829 lacked at least the fragments of the tcdC, tcdD, tcdB, and tcdE genes flanked by our primers while conserving at least the portion of the nonrepetitive region of the toxin A gene (figures 1 and 2, table 4). No amplification was obtained for genes tcdA and tcdC in C. difficile 8864, suggesting that this isolate lacks at least the fragments of tcdA and tcdC targeted by our primers; amplification products were obtained for tcdD, tcdB, and tcdE as previously reported [15] . We found no differences in the organization of the PaLoc among the toxigenic isolates (other than 8864 and P-829) regardless of source (patient or environment) and disease manifestations.
Discussion
Toxins A and B are considered the major virulence factors in C. difficile-associated diarrhea (CDAD). The PaLoc of Figure 1 . Ethidium bromide-stained 2% agarose gel of polymerase chain reaction products of DNA from Clostridium difficile strains amplified with primers directed at toxin A and B genes. Lanes are as follows: 1 and 15, 123-bp DNA marker ladder; 3-5 and 7-10, DNA from nontoxigenic and toxigenic strains, respectively; 12 and 13, DNA from C. difficile P-829 and 8864, respectively; 2, 6, 11, and 14, blank.
C. difficile includes the genes for toxins A and B (tcdA and tcdB) and 3 additional small ORFs: tcdD, tcdE, and tcdC. The interrelation of these genes or the role of tcdD, tcdE, and tcdC in the virulence of C. difficile is not known. Recent studies on the regulation of the toxin genes indicate that tcdD is involved in up-regulation of expression of toxins A and B [4, 5] , Conversely, a negative regulatory function has been proposed for tcdC, which is transcribed in the opposite direction [4, 5] . Aside from these limited studies, little is known about the stability and conservation of the PaLoc in C. difficile.
Our results show that the PaLoc is highly stable and conserved in toxigenic strains and that, in addition to defects in tcdA and tcdB, changes in the other genes of the PaLoc occur and may account for the virulence characteristics observed in some strains. C. difficile 8864 has a deletion in tcdC [15] , a finding confirmed by our results. The lack of a functional tcdC gene in strain 8864 may result in the lack of negative regulation of toxin expression, which may explain the higher cytotoxic activity of this isolate and supports the proposed function of tcdC [4, 5, 9] . Our isolate P-829, which is defective in tcdB, is also defective in the fragments of tcdD, tcdE, and tcdC targeted by our primers. Although this isolate has the portion of the toxin A gene amplified with our primers, toxin A was not detected by an ELISA, suggesting an altered toxin A not detectable by conventional methods. C. difficile P-829 was isolated from a case of recurrent CDAD. Although this isolate does not produce toxin B, its isolation from a clinical case suggests that strains deficient or with a modified toxin may still cause disease. As with 8864, a deletion in the tcdC gene of P-829 may result in deregulation in the production of an altered toxin A not detectable by ELISA but still capable of producing clinical disease. Figure 2 . Ethidium bromide-stained 2% agarose gel of polymerase chain reaction products of DNA from Clostridium difficile strains amplified with primers directed at genes tcdC-E, cdd-3, and cdu-2 of pathogenicity locus. Lanes are as follows: 1 and 15, 123-bp DNA marker ladder; 3-5 and 7-10, DNA from nontoxigenic and toxigenic strains, respectively; 12 and 13, DNA from C. difficile P-829 and 8864, respectively; 2, 6, 11, and 14, blank. In summary, the results obtained in this study indicate that the PaLoc is highly stable and conserved in toxigenic C. difficile, whereas nontoxigenic isolates lack the entire unit. In addition, isolates defective in у1 genes of the PaLoc can still be associated with clinical disease. Further studies are in progress in our laboratory to determine the role of the genes in the PaLoc and their interaction in the pathogenesis of C. difficile.
